Semaglutide's mood-lifting effects: real science or placebo?

What did @savannahkthrower actually say?

She reported that on day one of semaglutide, "the food noise was silenced" — meaning the constant mental chatter about eating stopped almost immediately. She also noted minimal side effects: one brief bout of nausea, a single headache on day two, and a weight drop of somewhere between 3.6 and 9 pounds in her first week. She was refreshingly honest about not knowing her exact starting weight.

The food noise description is the real substance of this video. She describes spending entire days mentally cycling through what to eat — "every action, every out, every like minute of the day" — and characterizes that experience as "literally suffocating." She frames the medication's effect on this as a life change, not just a diet tool. Worth noting: she also says she knows the medication "isn't for this," which suggests she's aware weight loss isn't the drug's primary indication.

Does the science back this up?

On food noise specifically, yes — and more rigorously than most TikTok claims deserve. The appetite-suppressing effects of GLP-1 receptor agonists like semaglutide are well-documented and do appear to kick in early, sometimes within days of the first dose.

Blundell et al. (2017, Diabetes, Obesity and Metabolism) found that liraglutide, a related GLP-1 agonist, significantly reduced appetite and food cravings independent of nausea, meaning the appetite reduction isn't just people eating less because they feel sick. More specifically to semaglutide, Rubino et al. (2021, JAMA) in the STEP 4 trial confirmed substantial reductions in hunger and food cravings over time. Research by van Bloemendaal et al. (2014, Diabetes, Obesity and Metabolism) pointed to GLP-1 receptors in the brain — specifically the hypothalamus and reward centers — as the mechanism behind reduced food-related thoughts, not just gut satiety signals. So when she says the drug quieted the psychological pull of food, that's not placebo talking. That's a plausible neurological effect with real mechanistic support.

What did they get wrong (or right)?

She got the food noise biology right, even if she didn't use clinical language. That's more than most influencer content manages. The weight numbers, though, are a mess — and she admits it herself, which earns some credit.

Losing 6 to 9 pounds in one week sounds dramatic, but it's almost certainly water weight and reduced gut content, not fat loss. Semaglutide slows gastric emptying significantly, which reduces the amount of food sitting in your digestive tract at any time. Weigh yourself before your first dose versus a week into slower digestion, and you'll see a drop that doesn't reflect actual fat tissue change. Clinical trials measure weight loss over months for a reason. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed an average of about 14.9% body weight loss over 68 weeks — not one week. She doesn't overclaim the weight number, she just reports it with appropriate confusion. That's fine. What would have been a problem is saying she "lost" that weight definitively. She didn't do that.

Her attribution of the day-two headache to either semaglutide or her menstrual cycle is actually reasonable clinical thinking. Headache is a listed side effect during initiation, but distinguishing it from cycle symptoms at the same time is genuinely difficult.

What should you actually know?

The food noise effect she describes is real, but week one is not a representative sample of how this medication behaves over time. Side effects — particularly nausea and vomiting — often worsen as doses increase during the titration period. Most clinical protocols start at 0.25mg weekly and increase every four weeks. The side effect profile at 0.5mg looks different than at 2.4mg.

A few things worth knowing before you decide her experience is yours:

• GLP-1 medications require medical supervision. Dose titration, contraindications (including a personal or family history of medullary thyroid carcinoma), and monitoring for pancreatitis are not optional considerations.
• Early weight drops are almost always misleading. Fat loss on semaglutide is real but slow. The STEP 1 trial average was about 15.3kg over 68 weeks in people with obesity.
• Food noise reduction varies. Not everyone experiences the same psychological quieting. Some patients report reduced cravings, others primarily notice nausea without appetite suppression.
• She says she hasn't gotten sick "yet" at 8 days. That's accurate hedging. Nausea affects roughly 44% of patients in clinical trials (Wilding et al., 2021).

The bottom line

This video is more grounded than most in the GLP-1 content space. She doesn't claim a cure, doesn't recommend a dose, and actively qualifies her experience as early and personal. The food noise mechanism she describes has legitimate scientific backing. The weight numbers are probably misleading in real terms, but she doesn't oversell them. For a one-week update with 1 million views, this one could have been a lot worse.